Research Site

Jingzhou 434000

1 studies enrolling now · 1 studies all time

What they study most

Non-squamous Non-small Cell Lung Cancer

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC — Recruiting now